Skip to main navigation

Home
Technology
- Product Details
- HIFU Technology
Physicians
- Prostate Cancer Management
- Clinical Information
Patients
Company

Menu

Home
Technology
- Product Details
- HIFU Technology
Physicians
- Prostate Cancer Management
- Clinical Information
Patients
Company

Focal One® - Investor Relations

Annual Reports

Investor Relations

Overview
News & Events
- News
- Events & Presentations
Financial Information
Stock Information
Corporate Governance
Investor Resources
- Contact Us
- Email Alerts

2003 Annual Report

2003 Annual Report

2002 Annual Report

2002 Annual Report

2001 Annual Report

2001 Annual Report

2000 Annual Report

2000 Annual Report

1999 Annual Report

1999 Annual Report

First page
Previous page
Page 1
Page 2
Current page 3

Investor Contact

Blandine Confort

bconfort@edap-tms.com

LifeSci Advisors, LLC

jfraunces@lifesciadvisors.com

Get Updates And Stay Connected

Get New Updates Directly To Your Inbox.

Email Address* Required

Focal One® - HIFU Prostate Tissue Ablation

Focal One^® has received regulatory clearance and is marketed in the United States, Europe, Canada, Korea, Russia, Brazil and other countries. In the United States, Focal One^® is indicated for the ablation of prostate tissue. Focal One^® is a registered trademark of EDAP TMS.

Discover More

EDAP TMS INFORMATION

P: +1(512) 832-7956
E: info@edap-usa.com
A: EDAP Technomed, Inc.
5321 Industrial Oaks Blvd, # 110
Austin, TX 78735